Stay updated on Adaptive TKI Therapy in Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Adaptive TKI Therapy in Thyroid Cancer Clinical Trial page.

Latest updates to the Adaptive TKI Therapy in Thyroid Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.2.0 updated to v3.3.2. No visible changes to study content or page structure are evident in the screenshot.SummaryDifference0.0%

- Check21 days agoChange DetectedRemoved the government funding lapse notice from the page. The study details, eligibility criteria, and outcomes sections remain unchanged.SummaryDifference0.3%

- Check36 days agoChange DetectedNo significant updates were detected to the study page between versions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check65 days agoChange DetectedMajor update: publishing a government funding/status notice and upgrading to v3.2.0; removal of specific thyroid cancer resources (Medullary and Differentiated thyroid carcinoma) from the Genetic and Rare Diseases Information Center.SummaryDifference3%

- Check72 days agoChange DetectedTerminology updated fromSummaryDifference0.1%

- Check86 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1; a 'Back to Top' link was removed.SummaryDifference0.1%

Stay in the know with updates to Adaptive TKI Therapy in Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adaptive TKI Therapy in Thyroid Cancer Clinical Trial page.